RaymondGeorgeMcKayMD
Cardiology • Hartford, CTAdult Congenital Heart Disease, Interventional Cardiology
Clinical Professor of Medicine, University Conn
Dr. McKay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
85 Seymour St
Ste. 821
Hartford, CT 06106Phone+1 860-545-5061Fax+1 860-545-3558
Summary
- Raymond McKay, MD, based in Hartford, CT, specializes in cardiology with subspecialties in interventional cardiology and structural heart disease. He currently serves as the Director of Research for the Hartford HealthCare Heart & Vascularf Institute. He is a graduate of Harvard Medical School, class of 1978, and he is experienced in general cardiology, cardiac critical care, diagnostic and therapeutic cardiac catheterization , TAVR and percutanis mitral valve repair. He has a total of over 500 peer-reviewed articles and abstracts. His recent publications have appeared in respected journals such as Advanced Science, JACC and The American Journal of Cardiology. McKay has participated in clinical trials focusing on the safety and efficacy of different TAVR bioprotheses for aortic stenosis. His accolades include being named a Regional Top Doctor by Castle Connolly and achieving CMS Meaningful Use Stage 1 Certification. He is also a Fellow of the American College of Cardiology.
Education & Training
Harvard Medical SchoolClass of 1978
Certifications & Licensure
CT State Medical License 1988 - 2025
MA State Medical License 1980 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- Diversity Recruitment in Cardiovascular Specialties: Barriers and Opportunities in Postgraduate Training Programs.Maria Guerrero, Edmund T Takata, Ervin Ham, Laura Hohenstein, Taylor Amore
JACC. Advances. 2025-02-01 - 1 citationsAI-Powered Multimodal Modeling of Personalized Hemodynamics in Aortic Stenosis.Caglar Ozturk, Daniel H Pak, Luca Rosalia, Debkalpa Goswami, Mary E Robakowski
Advanced Science. 2025-02-01 - 1 citationsTiming and Outcomes of PCI in Conjunction With TAVR With Balloon-Expandable Valves.Abhijeet Dhoble, Talha Ahmed, Raymond G Mckay, Chad Kliger, Nirat Beohar
JACC. Cardiovascular Interventions. 2025-01-27
Press Mentions
Inside Trump’s Supplement Regimen — and What Experts Say You Can Try TooOctober 6th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
